Free Trial
LON:MHC

MyHealthChecked (MHC) Share Price, News & Analysis

MyHealthChecked logo
GBX 18.17 +1.07 (+6.23%)
As of 01/21/2025 11:09 AM Eastern

About MyHealthChecked Stock (LON:MHC)

Key Stats

Today's Range
16.50
19.19
50-Day Range
10.50
18.17
52-Week Range
8
19.19
Volume
310,562 shs
Average Volume
114,656 shs
Market Capitalization
£9.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests. MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests have been made available online and for over-the-counter purchase. The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

Receive MHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MyHealthChecked and its competitors with MarketBeat's FREE daily newsletter.

MHC Stock News Headlines

Kamala’s final humiliation
Now, for the first time, I’m going to share these ten investments publicly – the same ones I’ve discussed behind closed doors with some of America’s savviest investors. The obscure, little-known companies we believe could 5x, even 10x, under Trump’s second term…
Oberon AIM VCT Ord (OVCT.L)
Returns At MyHealthChecked (LON:MHC) Are On The Way Up
See More Headlines

MHC Stock Analysis - Frequently Asked Questions

MyHealthChecked's stock was trading at GBX 12.50 at the beginning of the year. Since then, MHC shares have increased by 45.3% and is now trading at GBX 18.17.
View the best growth stocks for 2025 here
.

Shares of MHC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that MyHealthChecked investors own include Beowulf Mining (BEM), B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Gresham House Strategic (GHS) and Greencore Group (GNC).

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
16
Year Founded
N/A

Profitability

Net Income
£-1,040,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£9.39 million
Cash Flow
GBX 10.22 per share
Book Value
GBX 14 per share

Miscellaneous

Free Float
N/A
Market Cap
£9.45 million
Optionable
Not Optionable
Beta
1.37
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (LON:MHC) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners